TownSquare Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $904K | Buy |
7,158
+203
| +3% | +$26.7K | 0.17% | 114 |
|
|
2026
Q1 | $969K | Buy |
6,955
+198
| +3% | +$27.7K | 0.22% | 96 |
|
|
2025
Q4 | $829K | Sell |
6,757
-394
| -6% | -$47.9K | 0.19% | 108 |
|
|
2025
Q3 | $794K | Sell |
7,151
-5,145
| -42% | -$585K | 0.12% | 158 |
|
|
2025
Q2 | $1.36M | Sell |
12,296
-122,357
| -91% | -$13M | 0.13% | 147 |
|
|
2025
Q1 | $15.1M | Buy |
134,653
+1,000
| +0.7% | +$103K | 0.16% | 115 |
|
|
2024
Q4 | $12.3M | Sell |
133,653
-1,311
| -1% | -$118K | 0.14% | 131 |
|
|
2024
Q3 | $11.3M | Buy |
134,964
+16,996
| +14% | +$1.3M | 0.14% | 143 |
|
|
2024
Q2 | $8.09M | Buy |
117,968
+723
| +0.6% | +$48.2K | 0.11% | 181 |
|
|
2024
Q1 | $8.59M | Sell |
117,245
-20,535
| -15% | -$1.58M | 0.13% | 159 |
|
|
2023
Q4 | $11.2M | Buy |
137,780
+62,052
| +82% | +$4.83M | 0.19% | 105 |
|
|
2023
Q3 | $5.68M | Buy |
75,728
+6,294
| +9% | +$484K | 0.1% | 186 |
|
|
2023
Q2 | $5.35M | Buy |
69,434
+5,228
| +8% | +$417K | 0.1% | 199 |
|
|
2023
Q1 | $5.33M | Buy |
64,206
+1,981
| +3% | +$164K | 0.12% | 162 |
|
|
2022
Q4 | $5.34M | Sell |
62,225
-12,390
| -17% | -$981K | 0.13% | 147 |
|
|
2022
Q3 | $4.6M | Buy |
74,615
+892
| +1% | +$56.2K | 0.13% | 137 |
|
|
2022
Q2 | $4.56M | Buy |
73,723
+2,603
| +4% | +$161K | 0.13% | 145 |
|
|
2022
Q1 | $4.23M | Buy |
71,120
+6,203
| +10% | +$397K | 0.11% | 174 |
|
|
2021
Q4 | $4.71M | Sell |
64,917
-12,774
| -16% | -$880K | 0.12% | 149 |
|
|
2021
Q3 | $5.43M | Buy |
77,691
+7,440
| +11% | +$523K | 0.16% | 119 |
|
|
2021
Q2 | $4.81M | Buy |
70,251
+9,201
| +15% | +$614K | 0.16% | 116 |
|
|
2021
Q1 | $3.95M | Buy |
61,050
+14,824
| +32% | +$956K | 0.15% | 121 |
|
|
2020
Q4 | $2.69M | Buy |
46,226
+14,924
| +48% | +$901K | 0.12% | 151 |
|
|
2020
Q3 | $1.96M | Buy |
31,302
+2,414
| +8% | +$167K | 0.11% | 150 |
|
|
2020
Q2 | $2.21M | Buy |
28,888
+25,617
| +783% | +$1.96M | 0.15% | 120 |
|
|
2020
Q1 | $262K | Sell |
3,271
-353
| -10% | -$24.4K | 0.02% | 354 |
|
|
2019
Q4 | $235K | Sell |
3,624
-35
| -1% | -$2.28K | 0.02% | 397 |
|
|
2019
Q3 | $234K | Sell |
3,659
-281
| -7% | -$18.4K | 0.02% | 434 |
|
|
2019
Q2 | $256K | Sell |
3,940
-11,775
| -75% | -$775K | 0.02% | 395 |
|
|
2019
Q1 | $1.02M | Buy |
15,715
+12,039
| +328% | +$800K | 0.08% | 183 |
|
|
2018
Q4 | $249K | Buy |
+3,676
| New | +$257K | 0.03% | 324 |
|
Other funds holding GILD
TownSquare Capital's GILD Position: Q2 2026 in Review
TownSquare Capital increased its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, buying an estimated $26.7K and bringing the position to 7,158 shares worth $904K. The position accounts for 0.17% of the portfolio, ranked #114.
TownSquare Capital first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $15.1M in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- TownSquare Capital held 7,158 shares of Gilead Sciences worth $904K as of Q2 2026.
- TownSquare Capital bought 203 Gilead Sciences shares in Q2 2026, an estimated $26.7K.
- Gilead Sciences made up 0.17% of TownSquare Capital's portfolio in Q2 2026, its #114 holding.
- TownSquare Capital first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
- TownSquare Capital's Gilead Sciences position peaked at $15.1M in Q1 2025.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.